These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37240955)

  • 1. A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches.
    Sezai A; Sekino H; Taoka M; Osaka S; Tanaka M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Transdermal Bisoprolol Patch with Oral Bisoprolol Fumarate Administration as a Therapeutic Agent for Idiopathic Frequent Premature Ventricular Contractions.
    Shinohara M; Wada R; Yao S; Yano K; Akitsu K; Koike H; Kinoshita T; Yuzawa H; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 May; 61(3):510-516. PubMed ID: 32418969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients.
    Yasui T; Oka T; Shioyama W; Oboshi M; Fujita M
    SAGE Open Med; 2020; 8():2050312120907817. PubMed ID: 32128207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
    Yamamoto K; Miwa S; Yamada T; Setozaki S; Hamuro M; Kurokawa S; Enomoto S
    J Cardiothorac Surg; 2023 Apr; 18(1):103. PubMed ID: 37024987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
    Toda H; Nakamura K; Shimizu K; Ejiri K; Iwano T; Miyoshi T; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Hikasa Y; Hayashi M; Morita H; Morimatsu H; Ito H;
    Circ J; 2020 Mar; 84(4):642-649. PubMed ID: 32092717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
    Momomura SI; Saito Y; Yasumura Y; Yamamoto K; Sakata Y; Daimon M; Kinugawa K; Okamoto H; Dohi N; Komuro I
    Circ J; 2017 Dec; 82(1):141-147. PubMed ID: 28768917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy.
    Kim Tran S; Ngo TH; Phuong Nguyen AT; Ngoc Huynh HT; Vo CT; Bao Nguyen NN; Nguyen TH; Huynh MV
    Curr Hypertens Rev; 2023; 19(1):42-51. PubMed ID: 36627790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    Iwano T; Toda H; Nakamura K; Shimizu K; Ejiri K; Naito Y; Mori H; Masuda T; Miyoshi T; Yoshida M; Hikasa Y; Morimatsu H; Ito H;
    J Cardiol; 2021 Nov; 78(5):349-354. PubMed ID: 34083113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
    Yamashita T; Inoue H
    J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
    Cotton S; Devereux G; Abbas H; Briggs A; Campbell K; Chaudhuri R; Choudhury G; Dawson D; De Soyza A; Fielding S; Gompertz S; Haughney J; Lang CC; Lee AJ; MacLennan G; MacNee W; McCormack K; McMeekin N; Mills NL; Morice A; Norrie J; Petrie MC; Price D; Short P; Vestbo J; Walker P; Wedzicha J; Wilson A; Lipworth BJ
    Trials; 2022 Apr; 23(1):307. PubMed ID: 35422024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.